Azorim 2025: The Backlog Is There, but the Cash Has Not Arrived Yet
Azorim ended 2025 with higher revenue, net profit of NIS 240.2 million, and signed backlog of NIS 1.83 billion. The real issue is that cash is still lagging behind: unit sales fell, contract assets ballooned, and operating cash flow stayed deeply negative.
Getting To Know The Company
Azorim is still, first and foremost, a for sale residential developer. That is where most of the revenue comes from, and that is also where the core risk sits. It is easy to look at the company today and see a more diversified story than in the past: a rental housing leg in Israel, a US multifamily leg, some income producing assets in Israel, a large urban renewal pipeline, and a stable credit rating. All of that is true. It still does not change the basic fact that the group lives and dies on apartment sales, construction progress, handovers, and its ability to turn accounting profit into released project surplus and usable cash.
What is working right now is clear enough. Consolidated revenue rose to NIS 1.879 billion in 2025, net profit rose to NIS 240.2 million, and operating profit rose to NIS 454.5 million. The company also has real operating scale: 24 projects under construction or early marketing with 4,963 housing units, plus planning reserves of roughly 41,400 units. In Israeli rental housing it has 10 sites with about 1,835 units, of which 870 are occupied and income producing. In the US it has five residential buildings across operation, lease up, and development stages with 1,460 units.
This is also exactly where a superficial read can go wrong. Azorim ends the year with a sharp gap between earnings and cash. Apartment sales fell to just 331 units from 551 in 2024, customer contract collections fell to NIS 736 million from NIS 789 million, contract assets jumped to NIS 1.301 billion, and contract liabilities fell to just NIS 263 million. Put simply, the company recognized more and more revenue before the cash actually came in. That is the heart of the story.
Another point that can easily be missed is that the recurring leg is improving, but it is still not large enough to change the group economics. Azorim Living posted NOI of NIS 60.9 million and management FFO of NIS 6.2 million in 2025, after negative FFO of NIS 29.4 million in 2024. That is real improvement. It is still small next to group level operating cash outflow of NIS 809.1 million and a development machine that continues to require heavy funding.
The right frame for reading Azorim in 2025 is therefore not “a rental real estate company that has scaled up.” It is a large residential development platform with improving recurring support legs that is still fundamentally driven by working capital, funding, and delivery timing. The key question for 2026 is not whether the company has projects. It clearly does. The question is whether it can convert backlog and near term deliveries into accessible cash before a new wave of acquisitions absorbs the improvement again.
A Quick Economic Map
| Engine | What 2025 shows | Why it matters |
|---|---|---|
| Residential development in Israel | Segment revenue of NIS 1.770 billion and segment result of NIS 390.9 million | This is still the pace setter, both on the upside and on the downside |
| Rental housing in Israel | Revenue of NIS 84.3 million, NOI of NIS 60.9 million, management FFO of NIS 6.2 million | Real improvement, but still too small relative to group funding needs |
| Income producing assets in Israel | Segment revenue of NIS 41.8 million and segment result of NIS 88.5 million | Adds a more stable leg, but still at a limited scale |
| US rental housing | Segment revenue of NIS 51.3 million and segment result of NIS 89.9 million | Adds diversification and value, but also FX exposure and US execution risk |
This chart matters because it makes the central mismatch visible. Azorim did not lose just a little sales momentum. It moved from 551 units and NIS 1.557 billion of consideration in 2024 to 331 units and NIS 1.062 billion in 2025. That means the 2025 earnings base is being supported much more by revenue recognition from advanced projects than by fresh sales momentum.
Events And Triggers
What could release cash in the near term
Exchange Ramat Gan: This is the most immediate trigger. At the end of 2025 the project was 95% complete, with 287 units sold out of 355, cumulative revenue of NIS 919.3 million, and gross profit accumulated during 2025 of NIS 49.9 million. In January 2026 the company received Form 4 occupancy approval and began occupancy. That matters because the real 2026 test for Azorim is not more paper revenue, but actual handovers, collections, and surplus release. The picture is not perfectly clean here either: 75 units damaged by blast effects were excluded from the occupancy permit until repairs are completed.
The signed backlog: At the end of 2025, remaining revenue to be recognized from signed sale contracts stood at NIS 1.833 billion. At the same time, the company showed NIS 2.866 billion of expected customer advances and payments. Most of that is supposed to flow through 2026 and 2027. That gives the company decent revenue visibility, but it also sharpens the test point: if this backlog does not turn into real collections, the operating thesis is not enough.
This chart shows why 2026 is a cash conversion proof year. On paper there is enough here to support another strong year. In practice, 2025 already showed that recognized revenue and cash receipts are not the same thing.
What opens a new pipeline of cash uses
The Rishon LeZion land win: After year end, the company completed payment for a winning bid on land in Rishon LeZion on which 226 housing units can be built, at a consideration of roughly NIS 306.5 million plus VAT. This is not a small side deal. It adds meaningful residential pipeline, but it also adds a large capital use before the 2025 cash gap has been closed.
The Ramat Efal retail boulevard acquisition: In February 2026 Azorim signed an agreement to acquire roughly 4,500 gross square meters of retail space, plus 103 parking spaces and related storage, for about NIS 136.4 million plus VAT. Fifteen percent was paid on signing, 20% is due after 12 months, and 65% is due upon completion, targeted for the end of 2028. The deal broadens the recurring asset base, but it cannot be presented only as value creation. At the timing level it opens another capital commitment.
The Yuka Park MOU: This one requires discipline. It is not a binding acquisition, but a memorandum of understanding under which Azorim is examining an investment of up to NIS 40 million in Yuka Park, part of it for a 51% equity stake and part of it as a shareholder loan. The analytical implication is not that Azorim has already entered a new vertical. It is that management is signaling appetite for additional moves while the company has not yet proven full closure of its cash conversion gap.
The outside signal
Stable rating, with a clear caveat: In March 2026 Midroog affirmed the issuer rating at A1.il with a stable outlook, and kept the main bond ratings in place. That is the reassuring signal. The caveat is that the rating case assumes leverage improves in 2026 partly through more than NIS 600 million of project surplus releases, while also taking into account land and asset acquisitions of similar scale. In other words, even the external read is that deleveraging still needs to be proven rather than assumed.
Efficiency, Profitability, And Competition
Profit improved, but not because the market suddenly reopened
At the consolidated level, 2025 looks good. Revenue rose to NIS 1.879 billion, gross profit rose to NIS 471.8 million, and net profit rose to NIS 240.2 million. Within apartment sales, land sales, and construction services, revenue reached NIS 1.793 billion before the financing component adjustment, and gross profit rose to NIS 413.9 million. Gross margin on apartment sales also held at 25%.
Those numbers do not tell the whole story on their own. While revenue held up, fresh sales momentum weakened. The company sold just 331 housing units in 2025, compared with 551 in 2024 and 395 in 2023. Consideration also fell to NIS 1.062 billion from NIS 1.557 billion in 2024. That means 2025 results rely more on revenue recognition from advanced stage projects and less on fresh current demand.
Average price per unit rose to NIS 3.21 million before VAT, up from NIS 2.83 million in 2024. That is a positive datapoint, but it needs to be read carefully. It can reflect a better project mix rather than a stronger market. When unit volume drops this sharply, a higher average price is not enough to conclude that underlying demand improved.
Financing promotions have moved from marketing into accounting
This is probably the most important finding inside the profitability section. In 2025 Azorim reduced reported revenue by about NIS 24 million in order to reflect the time value effect embedded in 20:80 style payment structures. At the same time, it recognized NIS 25.5 million of financing income from that same component. This is not just a technical note. It is an indication that generous payment terms are no longer merely a way to support sales velocity. They are already changing the quality of reported revenue recognition.
Put differently, if a reader sees higher revenue and better earnings, the next question has to be who is paying for the gap. In 2025, part of the answer is that the company itself is financing time for the customer. That is not automatically negative, but it does mean that growth achieved under those terms is worth less than growth backed by faster cash collection.
The recurring leg is genuinely improving
This is where the read needs to stay fair. Azorim Living no longer looks like a story asset only. Revenue rose to NIS 67.8 million, total NOI rose to NIS 60.9 million, and Same Property NOI rose to NIS 57.2 million. Management FFO turned positive at NIS 6.2 million after negative NIS 29.4 million in 2024. That is a real quality improvement.
It still has to be kept in proportion. NIS 6.2 million of FFO is not a number that can currently change the economics of a group that just reported NIS 809.1 million of negative operating cash flow. It is the beginning of a more credible recurring leg, not yet a recurring engine that can carry the group.
Fair value gains also came back
There is another profitability layer worth stripping out. In 2025 the company recognized NIS 107.1 million of fair value and disposal gains from investment property, compared with a NIS 2.7 million loss in 2024. That helps both operating profit and the bottom line in a material way. So anyone looking only at net profit misses the fact that part of the improvement came from accounting value uplift, not just better cash economics.
Cash Flow, Debt, And Capital Structure
Where the cash flow got stuck
This is where all in cash flexibility is the right framing. The relevant question is not how much profit was generated before cash uses. It is how much cash actually remained after working capital, land, tax, investment, and debt needs. On that basis, 2025 was a weak year.
Operating cash flow was negative NIS 809.1 million, compared with negative NIS 364.8 million in 2024. Even before land changes, operating cash flow was negative NIS 755.4 million. Most of the damage came from a NIS 1.188 billion increase in inventory of buildings for sale, assets and liabilities from contracts, alongside NIS 53.7 million of land changes and NIS 19.7 million of cash tax payments. This is not a small mismatch that can be explained away with softer language. It is a reminder that Azorim still requires very large real time capital.
This chart captures the central Azorim paradox. Revenue went up and net profit went up, but cash outflow from operations widened materially. For an investor, that is not a footnote. It is the main question.
Working capital explains most of the gap
Contract assets from customers rose to NIS 1.301 billion in 2025 from NIS 788.9 million at the end of 2024. At the same time, contract liabilities fell to NIS 263.3 million from NIS 586.5 million. Cash collections from customer contracts were NIS 736 million, down from NIS 789 million in 2024.
This is one of the easiest places to get the story wrong if you only look at the headline lines. When contract assets balloon and contract liabilities shrink, the company is recognizing revenue ahead of cash. So 2025 was not only a year of generally tougher sector funding conditions. It was also a year in which Azorim itself pulled more economic weight from future cash into current earnings.
The debt stack, covenant layer, and liquidity cushion
The balance sheet ends 2025 with NIS 2.455 billion of short term bank and other credit, NIS 326.8 million of current bond maturities, NIS 778.6 million of long term bonds, and NIS 902.7 million of long term loans and credit balances. That does not mean the whole amount is under immediate pressure tomorrow morning. It does mean Azorim still carries a heavy capital structure, and every operational improvement has to be read against a sizeable financing machine.
On the other side, year end cash and cash equivalents stood at NIS 135.6 million, plus another NIS 228.8 million of restricted cash and deposits in project escrow accounts, together about NIS 364 million. The company also highlights that it had around NIS 2.6 billion of prime based debt at year end, so a 1% cut in interest rates would reduce financing costs by about NIS 26 million per year assuming a similar debt base. That is potentially helpful, but it is not a substitute for collection discipline and surplus release.
It also matters that the company remains in compliance with its bond covenants at year end 2025, including maximum net financial debt to net CAP of 78% and minimum equity thresholds ranging from NIS 700 million to NIS 1.1 billion by series. This is not yet a covenant breach story. The yellow flag is one step earlier: earnings and backlog are improving, but debt and working capital still need another proof cycle.
The dividend also says something
Azorim paid NIS 40 million of dividends during 2025. This is not a company threatening amount. It does tell us management felt comfortable returning capital to shareholders in a year when operating cash flow was still deeply negative. That can be read as a confidence signal. It can also be read as continued capital usage at a point where the cash picture had not yet stabilized. Both readings are fair, which is exactly why this is the type of move that needs to be tested from both sides.
Outlook And What Comes Next
Before getting into detail, these are the five points that will actually define Azorim’s 2026:
- Revenue is not the problem, cash still needs to prove itself. NIS 1.833 billion of signed revenue gives visibility, but 2025 already showed that revenue recognition and collection are not the same thing.
- Exchange is not just another project, it is a conversion test. After 95% completion and Form 4 in January 2026, the market will want handovers, surplus release, and cash.
- The recurring leg is improving, but it still does not fund the group. Positive NIS 6.2 million of FFO at Azorim Living is a start, not a solution.
- Interest rates can help, but they cannot clean up the whole picture on their own. NIS 2.6 billion of prime linked debt makes lower rates relevant, but lower rates do not erase working capital pressure.
- Capital allocation will make or break the story. If project surpluses are released and then immediately absorbed by new deals, deleveraging gets delayed again.
2026 is a cash conversion proof year
This is not a classic breakout year, and it is not yet a full stabilization year either. It is a cash conversion proof year. The company has enough advanced projects, enough signed revenue, and enough operating milestones to post another good reporting year. What is still missing is proof that the machine can release cash quickly enough.
Deliveries and occupancy during 2026, led by Exchange, need to show that backlog actually rolls into project surplus. The expected receipts line for 2026 and 2027 looks strong, but after 2025, investors cannot stop at a schedule table. They need to see the change in the cash flow statement itself.
The Phoenix partnership is a potential relief valve, not cash in hand
The framework agreement with Phoenix, up to NIS 350 million of equity investment into urban renewal project entities over 72 months, is important. It shows Azorim understands it cannot carry all of its growth on its own balance sheet. The problem is that, as of the date the annual report was approved, the conditions for actual investments had still not been completed. So at this stage it is more of a future pressure reliever than a current cash solution.
The recurring leg also has a less clean side
There is another point that can look technical but is actually material. Azorim holds 39.27 million Azorim Living shares, but shares above the 30% threshold are classified as dormant shares and do not carry voting or dividend rights. As of the report approval date, 9.87 million shares fell into that category. The implication is that the recurring leg does create value, but not all of that value is accessible to Azorim shareholders in the straightforward way a casual reader might assume.
This matters even more because at the end of 2025 the carrying value of the equity investment in Azorim Living stood at NIS 305.7 million, while the quoted market value was NIS 212.0 million. That does not mean the report is wrong. It does mean that the question “how much is the recurring leg worth” is not only about assets, but also about structure, accessibility, and actual shareholder economics.
Risks
Azorim’s main risk today is not a lack of projects, but too many simultaneous cash openings. The company enters 2026 with a strong backlog, but also with stretched working capital, rising contract assets, deeply negative operating cash flow, and a new wave of transactions that can require capital before older projects release it.
The second risk is the quality of sales. The drop to 331 units sold in the year, alongside generous payment structures that move part of the economics from revenue into financing income, means the market is still not clean. If 2026 requires continued use of aggressive payment support to maintain pace, the question will not just be how many units were sold, but on what terms.
The third risk is funding. Net finance expense rose to NIS 149.4 million, and total finance expense charged to profit and loss rose to NIS 212.5 million. The company is still within covenant limits, and the rating remains stable, but Midroog is also explicit that leverage is high relative to the rating and that 2026 improvement depends on project surplus release and disciplined acquisitions.
The fourth risk is FX exposure. In 2025 the company recorded NIS 69.6 million of foreign currency translation losses in OCI from foreign operations. This is not an immediate cash hit, but it is a reminder that the US leg adds not only diversification but also volatility.
Finally, there is also a strategy sprawl risk here. Residential development, Israeli rental housing, US rental housing, income producing assets, retail acquisition, a non binding industrial real estate style MOU, and a framework with an institutional partner. Each move can make sense on its own. Together, they demand a management team that can execute, fund, and still preserve capital discipline.
Conclusions
Azorim ends 2025 as a company that again proved its execution and revenue recognition capability, but has not yet proved cash conversion with the same force. What supports the thesis today is a strong backlog, advanced projects, and an improving recurring leg. What blocks a cleaner read is that cash is still lagging behind earnings, while a new acquisition pipeline has already opened. In the near and medium term, the market will mainly measure deliveries, project surplus release, and capital discipline.
The current thesis: Azorim looks better in the income statement than in the cash flow statement, and the real 2026 challenge is to prove that backlog and deliveries turn into cash before management releverages the story through new deals.
What changed versus the older Azorim read is fairly clear: the recurring leg is no longer negligible, but it is still not big enough to take control away from the development business; at the same time, the earnings to cash gap widened rather than narrowed. The strongest counter thesis is that this concern is overstated, because the company enters 2026 with NIS 1.833 billion of signed revenue, NIS 2.866 billion of expected receipts, near term deliveries, and a rate environment that may improve. That can happen. Until it shows up in cash, though, it is still a thesis that needs evidence.
What could change the market’s interpretation in the near and medium term is not another headline about backlog or a new land purchase. It is a report that shows real surplus release, lower working capital strain, and an acquisition pace that does not consume the improvement. This matters because the debate around Azorim is no longer whether it has activity. It is whether that activity can become accessible shareholder value without relying again and again on more debt and more time.
| Metric | Score | Explanation |
|---|---|---|
| Overall moat strength | 3.5 / 5 | Strong brand, broad project pipeline, and improving diversification, but no insulation from the funding cycle or sales pace |
| Overall risk level | 4.0 / 5 | Deeply negative operating cash flow, stretched working capital, high finance costs, and multiple post balance sheet capital uses |
| Value chain resilience | Medium | Good geographic spread and supportive partnerships, but still highly dependent on financing, contractors, and execution timing |
| Strategic clarity | Medium | The direction is understandable, build a broader platform, but capital allocation across development, recurring assets, and new deals still creates noise |
| Short interest stance | 2.26% of float, down from 3.03% in December | Above the sector average of 0.83%, with SIR at 9.35, which signals caution rather than an extreme bear position |
Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.
The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.
The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.
Azorim's post-balance-sheet acquisition wave may improve the asset mix, but for now it turns deleveraging from something that was supposed to flow from the existing project base into an execution test that requires project surpluses to arrive faster than new capital uses are bei…
Azorim Living is becoming a real stabilizing leg, but only part of that improvement is actually accessible to Azorim shareholders because the headline metrics are 100%-basis platform numbers, the holding above 30% is dormant, and carrying value still stands well above quoted mar…
At Azorim, signed backlog is not the issue. The issue is that revenue is moving ahead of collections, and favorable payment terms are pushing part of that gap into contract assets, finance income, and bridge funding.